Cancer chromosomal instability: therapeutic and diagnostic challenges - PubMed (original) (raw)

Review

Cancer chromosomal instability: therapeutic and diagnostic challenges

Nicholas McGranahan et al. EMBO Rep. 2012.

Abstract

Chromosomal instability (CIN)-which is a high rate of loss or gain of whole or parts of chromosomes-is a characteristic of most human cancers and a cause of tumour aneuploidy and intra-tumour heterogeneity. CIN is associated with poor patient outcome and drug resistance, which could be mediated by evolutionary adaptation fostered by intra-tumour heterogeneity. In this review, we discuss the clinical consequences of CIN and the challenges inherent to its measurement in tumour specimens. The relationship between CIN and prognosis supports assessment of CIN status in the clinical setting and suggests that stratifying tumours according to levels of CIN could facilitate clinical risk assessment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1

Figure 1

Numerical and structural chromosomal instability. Scheme showing whole chromosome gains and losses (numerical CIN) and sub-chromosomal gains, losses, inversions and translocations (structural CIN).

Figure 2

Figure 2

Mechanisms of chromosome missegregation in mitosis. (A) A wild-type division, producing identical daughter cells. (B–E) Mitotic errors that result in aneuploid daughter cells.

Figure 3

Figure 3

Direct methods to assess tumour CIN status. (A) Section from a renal cell carcinoma biopsy, hybridized to two fluorescently labelled centromere probes—chromosome 2 (green) and chromosome 15 (red). Variation in centromere copy number is evident between the nuclei. (B) DNA image cytometry profile for a diploid tumour (diploid DNA content determined relative to control diploid cells). (C) DNA image cytometry profile for an aneuploid tumour (determined relative to control diploid cells).

None

Nicholas McGranahan

None

Rebecca A Burrell

None

David Endesfelder

None

Marco R Novelli

None

Charles Swanton

Similar articles

Cited by

References

    1. Negrini S, Gorgoulis VG, Halazonetis TD (2010) Genomic instability—an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11: 220–228 - PubMed
    1. Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396: 643–649 - PubMed
    1. Geigl JB, Obenauf AC, Schwarzbraun T, Speicher MR (2008) Defining ‘chromosomal instability’. Trends Genet 24: 64–69 - PubMed
    1. Choi CM, Seo KW, Jang SJ, Oh YM, Shim TS, Kim WS, Lee DS, Lee SD (2009) Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: Fluorescence in situ hybridization analysis of paraffin-embedded tissue from Korean patients. Lung Cancer 64: 66–70 - PubMed
    1. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z (2006) A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38: 1043–1048 - PubMed

Publication types

MeSH terms

LinkOut - more resources